Application of CRISPR-Cas9 System to Study Biological Barriers to Drug Delivery
In recent years, sequence-specific clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated (Cas) systems have been widely used in genome editing of various cell types and organisms. The most developed and broadly used CRISPR-Cas system, CRISPR-Cas9, has benefited from th...
Main Authors: | Ji He, Riya Biswas, Piyush Bugde, Jiawei Li, Dong-Xu Liu, Yan Li |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/5/894 |
Similar Items
-
CRISPR/Cas9: Transcending the Reality of Genome Editing
by: Sergiu Chira, et al.
Published: (2017-06-01) -
Targeting Telomeres and Telomerase: Studies in Aging and Disease Utilizing CRISPR/Cas9 Technology
by: Andrew C. Brane, et al.
Published: (2019-02-01) -
CRISPR/Cas9 in Chronic Lymphocytic Leukemia
by: María Hernández-Sánchez
Published: (2022-05-01) -
A Review: CRISPR Cas System and the Mechanism With an Inhibition of Binding of CRISPR Cas‐9
by: Akram Hosen, et al.
Published: (2025-01-01) -
CRISPR/Cas9 technology in the modeling of and treatment of mucopolysaccharidosis
by: Mehran Reyhani-Ardabili, et al.
Published: (2024-09-01)